Next Gen: 8th Improving Bioavailabilty & Formulation Conference February 24-26, 2014, Philadelphia, PA

Strategies for Ensuring Optimum Solubility and Drug Viability

This summit investigates the core challenges to achieving maximum bioavailability in drug candidates as well as novel drug delivery solutions utilized to improve bioavailability, and expedite time-to-market of new chemical entities as well as reformulated therapeutics in the development pipeline.

For three days attendees will engage in workshops, panel discussions and case studies from distinguished representatives of companies such as Pfizer, Merck, Bristol-Myers Squibb, Astrazenenca, Regeneron and more.

The website: www.nextgenbioavailability.com

Overall the main topics and themes to be discussed include:

• Ocular and Parenteral Drug Delivery
• Hot melt extrusion Technology/Spray-drying techniques
• High Throughput Robotics for Solubility Screening
• Lipid Excipients: how they work and when to use them
• Frequency Modulated Drug Delivery- bonds with metal to increase solubility and timed release of drug into tissue.
• Bioactive materials in nano-medicines
• Active vs Passive Targeting of Drug Delivery Systems

Pre-Conference Workshop Day: Monday, February 24, 2014

• Workshop A: Addressing Solubility in the Designing of Solid Lipid NanoParticle Drug Delivery Systems. Workshop Leader: Ayman El-Kattan, Associate Research Fellow, Pfizer
• Workshop B: Examining Water Solubility and Lipophilicity in Toxicology Formulations
• Workshop C: Green NanoTechnology in Solubility

Main Conference Presentations: February 25-26, 2014

Articles - News